- $44.61bn
- $58.66bn
- $16.31bn
IQVIA rises after raising annual profit forecast
IQVIA Q2 revenue beats estimates; outlook raised
Brief: IQVIA Q2 Adjusted EPS USD 3.15 Vs. IBES Estimate USD 3.03
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Micron
U.S. STOCKS ON THE MOVE-Natera, nLIGHT, Forte Biosciences
U.S. STOCKS ON THE MOVE-Levi's, Meta, PepsiCo
U.S. STOCKS ON THE MOVE-Levi, Ionis Pharmaceuticals, Gloo Holdings
TD Cowen sees improving demand for contract research firms in Q2 2026
U.S. RESEARCH ROUNDUP-East West Bancorp, First Citizens Bancshares, UMB Financial
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Brief: IQVIA Prices €950 Million Senior Notes Due 2033
U.S. RESEARCH ROUNDUP-Aveanna Healthcare, Palo Alto, Ulta Beauty
Brief: IQVIA To Raise €950 Million Via Senior Notes Due 2033
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Charles River beats quarterly estimates on steady demand for drug development services
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel
IQVIA gains after raising annual profit forecast